HealthEquity (HQY) reported $299.93 million in income for the quarter ended July 2024, representing a year-over-year enhance of 23.2%. EPS of $0.86 for a similar interval compares to $0.53 a 12 months in the past.
The reported income represents a shock of +5.43% over the Zacks Consensus Estimate of $284.48 million. With the consensus EPS estimate being $0.70, the EPS shock was +22.86%.
Whereas traders intently watch year-over-year modifications in headline numbers — income and earnings — and the way they examine to Wall Avenue expectations to find out their subsequent plan of action, some key metrics all the time present a greater perception into an organization’s underlying efficiency.
Since these metrics play an important function in driving the top- and bottom-line numbers, evaluating them with the year-ago numbers and what analysts estimated about them helps traders higher challenge a inventory’s worth efficiency.
Right here is how HealthEquity carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Avenue analysts:
-
Whole HSA Belongings
: $29.47 billion versus the three-analyst common estimate of $27.68 billion.
-
Whole HSA investments
: $13.10 billion in comparison with the $11.50 billion common estimate based mostly on three analysts.
-
CDBs Accounts
: 6.9 million in comparison with the 6.84 million common estimate based mostly on three analysts.
-
Whole Accounts
: 16.28 million in comparison with the 16.02 million common estimate based mostly on three analysts.
-
Whole HSA money
: $16.37 billion in comparison with the $16.18 billion common estimate based mostly on three analysts.
-
HSAs Accounts
: 9.38 million versus 9.17 million estimated by three analysts on common.
-
Income- Service
: $116.72 million versus the four-analyst common estimate of $116.66 million. The reported quantity represents a year-over-year change of +10.4%.
-
Income- Custodial
: $138.68 million versus $126.21 million estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a +40.2% change.
-
Income- Interchange
: $44.52 million versus $42.29 million estimated by 4 analysts on common. In comparison with the year-ago quarter, this quantity represents a +14.4% change.
View all Key Company Metrics for HealthEquity here>>>
Shares of HealthEquity have returned +17% over the previous month versus the Zacks S&P 500 composite’s +5.8% change. The inventory at the moment has a Zacks Rank #3 (Maintain), indicating that it may carry out in step with the broader market within the close to time period.
7 Finest Shares for the Subsequent 30 Days
Simply launched: Consultants distill 7 elite shares from the present checklist of 220 Zacks Rank #1 Robust Buys. They deem these tickers “Most Possible for Early Value Pops.”
Since 1988, the complete checklist has crushed the market greater than 2X over with a mean achieve of +23.7% per 12 months. So remember to give these hand picked 7 your rapid consideration.
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
